Chief Medical Officer @ (May 2025 - December 2025)
VP Global Medical Affairs | Insights and Strategy @ (August 2021 - May 2023)
Head of Medical Affairs APAC @ (March 2019 - August 2021)
Chief Medical Officer @ Kazia Therapeutics (formerly Novogen) (October 2016 - February 2018)
Medical Director @ (September 2015 - November 2016)
VP Global Centre of Excellence for Patient Centricity @ (July 2014 - August 2015)
Vice-President, Regional Medical Officer Japan and Pacific @ (July 2011 - July 2014)
VP Medical Affairs, Asia-Pacific and Japan @ (August 2009 - June 2011)
Scientific Affairs Director Australia and New Zealand @ (January 2007 - August 2009)
Medical Director Australia and New Zealand @ Eli Lilly Australia & New Zealand (February 2005 - January 2007)
Director Clinical Outcomes Research Institute @ Eli Lilly Australia & New Zealand (September 2003 - February 2005)
Medical Director @ Eli Lilly South Africa (August 2000 - December 2002)
Medical Director @ Searle, South Africa (January 1996 - January 2001)
Gordon Hirsch Education
Grey College 1982
College of Medicine of South Africa
MBBCh
University of the Witwatersrand
Master of Business Administration (MBA)
Henley Business School
FCP (SA)
University of the Witwatersrand
BSc Hons
Gordon Hirsch Skills
Adaptive Leadership
Crisis Management
Financial Planning
Business Acumen
Team Effectiveness
Project Management
Analytical Skills
Organizational Behavior
Executive Leadership
Strategic Thinking
Executive-level Communication
Proposal Writing
Pharmaceuticals
Study Reports
Clinical Study Design
Stakeholder Engagement
Problem Solving
Pharmaceutical Companies
Leadership
Strategic Leadership
Cross-functional Team Leadership
Organizational Leadership
Business Model Innovation
Patient Advocacy
Patient Outcomes
Life Sciences
Change Management
CTMS
Medical Affairs
GCP
Pharmaceutical Sales
Business Strategy
Pharmaceutical Industry
Drug Development
Medicine
Lifesciences
Clinical Development
Clinical Research
Management
Biotechnology
Strategic Planning
Regulatory Affairs
Medical Writing
Therapeutic Areas
Pharmacovigilance
Clinical Trials
Rheumatology
Consulting
Healthcare
Standard Operating Procedure (SOP)
Biopharmaceuticals
Team Leadership
Strategy
CRO Management
Cardiology
Dermatology
Neurology
Infectious Diseases
Medical Devices
Oncology
Cross Functional Team Leadership
Endocrinology
Vaccines
Diabetes
Science
Market Access
Gordon Hirsch Summary
Gordon Hirsch, based in Australia, is currently a Consultant at GHC (Gordon Hirsch Consulting). Gordon Hirsch brings experience from previous roles at Servatus Ltd, BioMarin Pharmaceutical Inc. and Kazia Therapeutics (formerly Novogen). Gordon Hirsch holds a Grey College. With a robust skill set that includes Adaptive Leadership, Crisis Management, Financial Planning, Business Acumen, Team Effectiveness and more. Gordon Hirsch has 1 emails on RocketReach.
Looking for a different Gordon Hirsch?
Find contact details for 700 million professionals.